Abstract
A workshop entitled The Development of Antisense Oligonucleotide Therapies for Duchenne Muscular Dystrophy, sponsored by the EU funded Clinical Network TREAT-NMD (Translational Research in Europe for the Assessment and Treatment of Neuromuscular Diseases; www.treat-nmd.eu), Association Francaise contre les Myopathies, Duchenne Parent Project, European Medicines Agency, Muscular Dystrophy Association and Patient Project Muscular Dystrophy, was held on 25th September 2009 at the European Medicines Agency (EMA), London, UK.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
